September 05, 2017
Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Monday, September 11
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--Sep. 5, 2017--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F.
Milligan, PhD, Gilead’s President and Chief Executive Officer, Robin L.
Washington, Gilead’s Executive Vice President and Chief Financial
Officer, and Alessandro Riva, Senior Vice President, Hematology and
Oncology Therapeutic Area Head, will participate in a fireside chat at
the Morgan Stanley Global Healthcare Conference in New York on Monday,
September 11 at 9:55 a.m. Eastern Time.
The audio portion of the fireside chat will be accessible live through
the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be required to listen to the webcast. The replay will
be available for 14 days following the presentation.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170905005133/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792